| Cytori Receives Patent on Core Celution(R) System Technology |
|
SAN DIEGO, Jun 09, 2008 (BUSINESS WIRE) --
Cytori Therapeutics (NASDAQ:CYTX) received Notification of Issuance from the United States Patent & Trademark Office for its core patent covering the Celution(R) System (USPTO # 7,390,484). This patent protects Cytori's key device technology, which processes adult stem and regenerative cells from adipose tissue at the patient's bedside. |
View past newsletters
Click Here
Since its inception in 2002, IFATS has been the world's only interdisciplinary fat tissue society. IFATS uniquely brings together different disciplines within the field in order to share knowledge, influence policy, and exchange new ideas.
Click here to pay your membership dues.
To view the abstracts please log in.
View IFATS Photo Galleries
To view the membership directory please log in.
|
|
Brought to you by the Stem Cells Journal.
Uniting researchers,
resources, and
the scientific community.
